Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MSD CONSUMER PRODUCTS, INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC.
Case Number:
3:11-cv-07437
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 20, 2013
Zydus Defends Obvious Challenge In Zegerid Patent Row
Zydus Pharmaceuticals USA Inc., which was sued in New Jersey federal court for developing a generic version of the heartburn drug Zegerid, said on Friday that a Federal Circuit decision in a parallel case doesn't preclude it from arguing that a Santarus Inc. patent Zydus allegedly infringes is obvious.
-
December 23, 2011
Santarus Tries To Shoot Down Zydus' Generic Zegerid
Santarus Inc. and the University of Missouri on Wednesday struck Zydus Pharmaceuticals USA Inc. with a patent infringement suit in New Jersey federal court, continuing an ongoing fight to block generic versions of the heartburn drug Zegerid.